| scholarly article | Q13442814 |
| P2093 | author name string | X J Huang | |
| L P Xu | |||
| P2860 | cites work | Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease | Q33340454 |
| Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults | Q33415603 | ||
| Engraftment syndrome following hematopoietic stem cell transplantation | Q34298239 | ||
| National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report | Q34474243 | ||
| A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease | Q34522152 | ||
| Multicenter phase II study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG). | Q34544439 | ||
| How I treat refractory acute GVHD. | Q35828633 | ||
| Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease | Q35897164 | ||
| Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease | Q36615576 | ||
| Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes | Q37143633 | ||
| Extra corporeal photochemotherapy in steroid refractory graft versus host disease: A review of guidelines and recommendations | Q39209287 | ||
| Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria | Q40563612 | ||
| Efficacy and security of matched unrelated donor hematopoietic stem cell transplant with transfusion of multipotent mesenchymal cells in pediatric severe aplastic anemia | Q40608862 | ||
| Controlled, Randomized, Open-Label Trial of Risk-Stratified Corticosteroid Prevention of Acute Graft-Versus-Host Disease After Haploidentical Transplantation. | Q40708932 | ||
| A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment | Q42097784 | ||
| Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trial. | Q42251937 | ||
| Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation | Q42539545 | ||
| Good outcome of haploidentical hematopoietic SCT as a salvage therapy in children and adolescents with acquired severe aplastic anemia | Q43531855 | ||
| Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin | Q43662951 | ||
| Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab | Q44092412 | ||
| Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial | Q44892383 | ||
| Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study | Q45278122 | ||
| Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis | Q45851521 | ||
| Reduced intensity of BuCy conditioning regimen for transplantation in the treatment of malignant hematologic diseases | Q46539562 | ||
| Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice. | Q50798708 | ||
| Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantation. | Q50847625 | ||
| Basiliximab for the treatment of steroid-refractory acute graft-versus-host disease after unmanipulated HLA-mismatched/haploidentical hematopoietic stem cell transplantation. | Q51025819 | ||
| Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study. | Q54035816 | ||
| Etiology and outcome of diarrhea after marrow transplantation: a prospective study. | Q54624604 | ||
| Diagnosis and management of chronic graft-versus-host disease | Q56963759 | ||
| Combination antithymocyte globulin and soluble TNFα inhibitor (etanercept) +/− mycophenolate mofetil for treatment of steroid refractory acute graft-versus-host disease | Q57252632 | ||
| Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors | Q70051817 | ||
| Prednisone therapy for acute graft-versus-host disease: short- versus long-term treatment. A prospective randomized trial | Q72537942 | ||
| Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors | Q74296144 | ||
| Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation | Q80177840 | ||
| Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation | Q81872765 | ||
| Partially matched related donor transplantation can achieve outcomes comparable with unrelated donor transplantation for patients with hematologic malignancies | Q84191205 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | Chinese | Q7850 |
| P304 | page(s) | 649-655 | |
| P577 | publication date | 2017-08-01 | |
| P1433 | published in | Chinese Journal of Hematology | Q27714364 |
| P1476 | title | How I treat acute graft versus host disease | |
| P478 | volume | 38 |
| Q90068110 | [Risk factors analysis for steroid-resistant acute graft versus host disease after haploidentical hematopoietic stem cell transplantation] | cites work | P2860 |
Search more.